Log In
Print this Print this

subcutaneous ALD403

  Manage Alerts
Collapse Summary General Information
Company Alder BioPharmaceuticals Inc.
DescriptionMAb targeting calcitonin gene-related peptide (CGRP)
Molecular Target Calcitonin gene-related peptide (CGRP)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationMigraine
Indication Details Prevent frequent episodic migraines; Treat migraine
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today